Postural orthostatic tachycardia syndrome (POTS) and small intestinal bacterial overgrowth (SIBO) co-occur at rates that cannot be explained by coincidence. A 2020 study published in Neurogastroenterology & Motility by Weinstock et al. found that 69% of POTS patients tested positive for SIBO via lactulose breath testing -- compared to roughly 10-15% in the general population. The connection runs through the autonomic nervous system: the same dysfunction that causes your heart rate to spike when you stand up also impairs the gut motility mechanisms that keep bacteria from overgrowth. If you have POTS and chronic GI symptoms that never fully resolve, or if you have SIBO that keeps relapsing despite proper treatment, the other condition may be the missing piece. Understanding this overlap changes how both conditions should be treated.
What Is POTS?
POTS is a form of dysautonomia characterized by an excessive increase in heart rate (30+ beats per minute or above 120 bpm) within 10 minutes of standing, without a corresponding drop in blood pressure. It affects an estimated 1-3 million Americans, predominantly women aged 15-50. Symptoms extend far beyond heart rate: chronic fatigue, exercise intolerance, brain fog, lightheadedness, nausea, temperature dysregulation, and -- critically for this discussion -- pervasive gastrointestinal dysfunction including bloating, constipation, early satiety, and abdominal pain. POTS is not a single disease but a syndrome with multiple subtypes: neuropathic (small fiber neuropathy damaging autonomic nerves), hyperadrenergic (excess norepinephrine), and hypovolemic (low blood volume). Each subtype can impair gut function through slightly different mechanisms, but the result is the same: reduced autonomic control over the gastrointestinal tract.
The 69% Statistic: What the Weinstock Study Found
69% of POTS patients tested positive for SIBO in the Weinstock et al. 2020 study -- a rate approximately 4-5 times higher than the general population. The study evaluated 272 patients with confirmed POTS using lactulose breath testing and found hydrogen-positive SIBO in the majority, with methane-positive IMO (intestinal methanogen overgrowth) in a smaller but significant subset. Patients with positive SIBO tests had significantly worse GI symptom scores, higher rates of nausea, and more severe bloating than POTS patients who tested negative. The study also found that SIBO-positive POTS patients had lower quality-of-life scores overall, suggesting that untreated SIBO is a major contributor to POTS disease burden. Importantly, many of these patients had been evaluated by gastroenterologists and diagnosed with IBS without ever being tested for SIBO.
How Autonomic Dysfunction Causes SIBO
The autonomic nervous system directly controls the migrating motor complex (MMC) -- the sweeping wave of contractions that clears bacteria from the small intestine every 90-120 minutes between meals. The vagus nerve, the primary parasympathetic nerve, initiates MMC phase III contractions. In POTS, autonomic dysfunction reduces vagal tone, weakens or eliminates MMC cycling, and slows overall gut transit time. A 2019 study in Autonomic Neuroscience demonstrated that POTS patients had significantly delayed gastric emptying and reduced small bowel transit compared to controls. When gut motility slows, bacteria that are normally swept into the colon accumulate in the small intestine. The small intestine also relies on autonomic signaling to regulate the ileocecal valve (the gate between small and large intestine) -- impaired valve function allows colonic bacteria to reflux into the small intestine, further contributing to overgrowth.
âšī¸The MMC only functions during fasting states (4-5 hours between meals). POTS patients who graze frequently to manage blood sugar or blood pressure inadvertently suppress the MMC, compounding the motility impairment caused by autonomic dysfunction.
Diagnostic Overlap: Symptoms Shared by POTS and SIBO
| Symptom | Seen in POTS | Seen in SIBO | Notes |
|---|---|---|---|
| Fatigue | Yes | Yes | Among the most debilitating in both conditions |
| Brain fog | Yes | Yes | D-lactate from SIBO bacteria can worsen cognitive issues in POTS |
| Nausea | Yes | Yes | Autonomic nausea vs. fermentation-driven nausea -- hard to distinguish |
| Bloating | Yes | Yes | SIBO bloating often worsens with meals; POTS bloating may worsen with standing |
| Abdominal pain | Yes | Yes | Gas distension in SIBO; blood pooling in POTS |
| Constipation | Yes (autonomic) | Yes (methane/IMO) | Methane slows transit; autonomic dysfunction slows transit |
| Diarrhea | Occasionally | Yes (hydrogen) | Hydrogen SIBO classically causes loose stools |
| Heart palpitations | Yes (hallmark) | Yes (less common) | SIBO can cause palpitations via vagal irritation or histamine release |
Treatment Considerations: Why Prokinetics Are Extra Important
Prokinetic therapy is the single most critical component of SIBO treatment in POTS patients because the underlying motility impairment is ongoing and structural, not temporary. Standard SIBO treatment follows the pattern: antimicrobials to clear overgrowth, then prokinetics to prevent relapse. In POTS patients, the autonomic dysfunction that caused the motility impairment persists, making relapse almost certain without aggressive prokinetic support. Low-dose erythromycin (50 mg at bedtime) is a motilin receptor agonist that stimulates MMC activity. Prucalopride (1-2 mg daily), a 5-HT4 agonist, accelerates colonic transit and has emerging evidence for small bowel motility benefits. Low-dose naltrexone (LDN) at 1.5-4.5 mg has dual utility: it modulates gut motility and reduces neuroinflammation, which may benefit both SIBO and POTS. All prescription prokinetics require physician oversight and monitoring.
â ī¸All medications mentioned in this article require a prescription and should only be used under direct medical supervision. Prokinetic agents can have side effects including cardiac conduction changes (erythromycin), diarrhea (prucalopride), and initial symptom flares. Do not self-prescribe based on this information.
The hEDS-POTS-SIBO-MCAS Cluster
Approximately 50-80% of POTS patients also meet criteria for hypermobile Ehlers-Danlos syndrome (hEDS), and this cluster carries an exceptionally high rate of both SIBO and mast cell activation syndrome (MCAS). The proposed mechanism: connective tissue laxity in hEDS affects the structural integrity of the gut wall and autonomic nerve fibers, leading to dysmotility. MCAS adds mast cell-driven inflammation that increases intestinal permeability and further impairs motility. A 2023 retrospective review at a major dysautonomia center found that patients with all four conditions (hEDS, POTS, SIBO, MCAS) had a SIBO relapse rate of 78% within 12 months, compared to 44% in patients with SIBO alone. Treating this cluster requires addressing each component: connective tissue support, autonomic stabilization, antimicrobial and prokinetic SIBO treatment, and mast cell stabilizers (cromolyn sodium, ketotifen, or H1/H2 antihistamines). Leaving any one untreated undermines the others.
Lifestyle Strategies That Help Both POTS and SIBO
Interventions that benefit both conditions simultaneously:
- Salt loading (2-3 grams of supplemental sodium daily for POTS) -- also supports stomach acid production needed for bacterial defense
- Hydration (2-3 liters daily) -- improves blood volume for POTS and supports digestive secretions for SIBO defense
- Compression garments (waist-high, 20-30 mmHg) -- reduce blood pooling that worsens both autonomic and GI symptoms
- Meal spacing (4-5 hours between meals) -- allows MMC cycling for SIBO clearance while POTS patients can add a small protein snack if blood sugar drops
- Gentle exercise (recumbent bike, swimming, rowing) -- improves autonomic tone and vagal function, which benefits gut motility
- Elevating the head of bed 6-8 inches -- helps both orthostatic intolerance and nighttime reflux/motility
Sequence of Treatment: Which Do You Treat First?
Treat both simultaneously whenever possible, but stabilize POTS enough to tolerate SIBO treatment first. SIBO antimicrobials (rifaximin, herbal protocols) can temporarily worsen POTS symptoms through die-off reactions, histamine release, and fluid shifts. Patients should have a baseline POTS management regimen in place (salt, fluids, compression, and any prescribed medications like fludrocortisone, midodrine, or beta-blockers) before starting SIBO treatment. Once POTS is managed to a functional baseline, begin standard SIBO antimicrobial therapy with the addition of prokinetics from day one -- not as an afterthought. After antimicrobial treatment, continue prokinetics indefinitely (or until the autonomic dysfunction resolves, which may take months to years). Retest SIBO via breath testing at 4-6 weeks post-treatment and every 3-6 months during the first year given the high relapse rate in this population.
Can treating SIBO improve my POTS symptoms?
Yes, in some patients. The Weinstock study found that SIBO treatment led to improvement in GI symptoms and overall quality of life in POTS patients. There are also case reports of POTS patients experiencing reduced tachycardia and improved orthostatic tolerance after SIBO clearance, possibly because gut inflammation and bacterial endotoxins contribute to autonomic dysfunction. However, POTS is multifactorial, and SIBO treatment alone is unlikely to resolve all POTS symptoms. Consider it one critical piece of a comprehensive treatment plan.
Should I see a gastroenterologist or a neurologist?
Ideally both, but finding a practitioner who understands the overlap is more important than their specialty. Many POTS patients are managed by cardiologists or neurologists who do not test for SIBO, while gastroenterologists may not recognize POTS-driven dysmotility as a root cause. Ask your provider directly whether they are familiar with the POTS-SIBO connection. Dysautonomia-focused clinics and integrative gastroenterologists are most likely to evaluate and treat both conditions.
Why does eating make my POTS worse -- is that SIBO?
It can be both. Eating triggers blood flow redistribution to the gut (postprandial splanchnic blood pooling), which worsens POTS symptoms in many patients -- this is autonomic, not SIBO-related. However, if the worsening includes significant bloating, gas, brain fog, or abdominal distension within 30-90 minutes of eating, SIBO fermentation is likely contributing. SIBO breath testing can help differentiate the two causes. Many POTS patients have both mechanisms occurring simultaneously.